Login

Ownership

13F as of Q2 2026 · 52.1M shares outstanding

Who owns SOLENO THERAPEUTICS INC?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership
0.0%
-100.0 pts vs last qtr
Institutional holders
0
-230 vs last qtr
Net shares bought
−62.4M
by institutions in Q2 2026
New / sold out
0 / 230
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • Janus Henderson Group PLC SOLD OUT −7.1M
  • FMR LLC SOLD OUT −5.8M

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for SOLENO THERAPEUTICS INC in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2017–FY2025
+8652.4%
+74.89% a year
Each share's claim on the business
−98.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$100M vs $162M
over 9 fiscal years
Diluted shares, split-adjusted
580.6K26.7M52.9M2017: 598.5K shares'172018: 1.4M shares'182019: 2.3M shares'192020: 4.2M shares'202021: 5.3M shares'212022: 8.4M shares'222023: 16.5M shares'232024: 40.2M shares'242025: 52.4M shares'25
Buybacks Stock-based comp
$0$50.1M$100.1M2017 buybacks: $02017 stock comp: $880.0K'172018 buybacks: $02018 stock comp: $1.3M'182019 buybacks: $02019 stock comp: $825.0K'192020 buybacks: $02020 stock comp: $1.5M'202021 buybacks: $02021 stock comp: $3.3M'212022 buybacks: $02022 stock comp: $2.5M'222023 buybacks: $02023 stock comp: $5.9M'232024 buybacks: $02024 stock comp: $100.0M'242025 buybacks: $100.1M2025 stock comp: $45.8M'25

How patient are the owners?

No 13F manager reports holding SOLENO THERAPEUTICS INC.

Super Investors

Investment managers reporting SOLENO THERAPEUTICS INC on Form 13F
JH
Janus Henderson Group PLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
F
FMR LLC
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—

3 more super investors behind a free account

See every manager holding SOLENO THERAPEUTICS INC, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting SOLENO THERAPEUTICS INC on Form N-PORT; together they hold 50.7% of the company
VH
Vanguard Specialized Funds
Position value
$93.2M
% of company
4.64%
% of the fund
0.24%
As of
January 31, 2026
SA
Fidelity Rutland Square Trust II
Position value
$76M
% of company
3.73%
% of the fund
0.03%
As of
February 28, 2026

23 more funds behind a free account

See every fund holding SOLENO THERAPEUTICS INC and how much of the fund the position is.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support